Rafferty Asset Management, LLC Dynavax Technologies Corp Transaction History
Rafferty Asset Management, LLC
- $29.4 Billion
- Q2 2025
A detailed history of Rafferty Asset Management, LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 162,690 shares of DVAX stock, worth $1.79 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
162,690
Previous 164,371
1.02%
Holding current value
$1.79 Million
Previous $2.13 Million
24.31%
% of portfolio
0.01%
Previous 0.01%
Shares
25 transactions
Others Institutions Holding DVAX
# of Institutions
292Shares Held
120MCall Options Held
294KPut Options Held
86.1K-
Black Rock Inc. New York, NY21.9MShares$241 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$196 Million6.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.1MShares$89 Million0.0% of portfolio
-
State Street Corp Boston, MA6.4MShares$70.3 Million0.0% of portfolio
-
Chicago Capital, LLC4.31MShares$47.4 Million1.06% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.39B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...